Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System

Clinical trial NCT02343081 · COMPLETED

Trial details

NCT number: NCT02343081
Sponsor: Monte Verde SA
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Brain Neoplasms, Malignant, Primary

Start date: 2012-01-01
Primary completion: 2013-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.